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Autophagy is a cellular “self-digestion” process known to be essential for various
physiological and pathological pathways, including cancer, where its role appears to
be context-dependent. In this work, we aimed to investigate the level of autophagy by
evaluating the expression of key autophagy-related proteins (ATGs) in testicular germ
cell tumors (TGCT) for which autophagy has been rarely investigated. We decided to use
an immunohistochemical (IHC) staining approach employing a tissue microarray (TMA).
Software-based evaluation of the integrated optical densities (IODs) of these proteins
indicated a significant downregulation of ATG1, ATG5, and ATG16L1. Accordingly,
reduced levels of microtubule-associated proteins 1A/1B light chain 3B (LC3B) were
found to parallel increases in sequestosome-1 (SQSTM1 or p62), a protein normally
degraded via autophagy, suggesting an in vivo reduction in autophagy with TGCT.
Thus, our work provides evidence for a tumor suppressive function of autophagy in
the development of TGCT and supports the concept of a context-dependent role of
autophagy in tumorigenesis which is tumor type-dependent.
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INTRODUCTION
Autophagy as a cellular catabolic process is essential at a basal level to ensure normal cellular
homeostasis by the controlled degradation of cellular contents (1, 2). It is highly regulated by
the so-called ATGs as well as by class III PI3K and mTOR pathways (3). Under most stress
conditions, for example a shortage of nutrients, autophagy is induced to cope with starvation by
degrading cellular proteins. Induction of autophagy is often observed in cancer cells experiencing
an anti-cancer therapy which involves drastic metabolic disturbances and/or DNA damage (4).
Therefore, inhibition of autophagy has been proposed as a combination with conventional anti-
cancer therapies for improving efficacy of the anti-cancer treatment and/or to overcome drug
resistance (3, 4). However, it is important to note the potential for dual roles of autophagy in cancer,
both as “friend” and “foe” (3–5).
Liu et al. Reduced Autophagy in TGCT
Our previous work showed a downregulation of ATG5 and
autophagy in melanoma and provided evidence that enforced
downregulation of ATG5 accelerates cell proliferation by
delaying oncogene-induced senescence (6–8). A protective
function of autophagy in early tumorigenesis has been
demonstrated in an experimental tumor model (9). Interestingly,
a dual role for autophagy was also shown in a mouse lung tumor
model, autophagy-deficient mice showing accelerated tumor
initiation, but prolonged overall survival (10).
Given the importance of autophagy in tumorigenesis
and anti-cancer therapy, we decided to investigate the level
of autophagy in TGCT for which the role of autophagy
has been little documented. IHC staining of the key
autophagy-regulating proteins followed by software-based
quantification of the integrated optical densities (IODs) of
the corresponding images revealed a reduction in ATG1,
ATG5, and ATG16L1 expression. Accordingly, we found
also a reduced level of LC3B accompanied by an increased
level of p62, indicating diminished basal autophagy in
TGCT.
MATERIALS AND METHODS
IHC Staining
The TMA was constructed by the Department of Pathology and
Molecular Pathology, University and University Hospital Zurich.
The study was approved by the Cantonal Ethics Committee
of Zurich (KEK-ZH-Nr. 2014-0604). The retrospective use
of tumor tissues of patients is in accordance with the
Swiss Law (“Humanforschungsgesetz”), which, according
to Article 34, allows the use of biomaterial and patient data
for research purposes without informed consent under certain
conditions that include the present cases. Law abidance
of this study was reviewed and approved by the Ethics
Commission of the Canton Zurich. IHC was performed
as previously described (6). The following antibodies were
used: anti-ATG1 (AP8104b, Abgent), anti-ATG5 (11C3,
Nanotools), anti-ATG16L1 (LS-B2723, Lifespan Biosciences),
anti-LC3B (023-100, Nanotools), and anti-p62 (P0067,
Sigma).
Quantification of the Staining Intensity
The staining intensities of these proteins were quantified as IODs
using Image Pro Plus software as previously described (6).
Statistics
Statistical analysis was performed using the unpaired Student
t-test or ANOVA followed by the Bonferroni test for multiple
comparisons as indicated.
Abbreviations: ATG, Autophagy-related proteins; TGCT, testicular germ cell
tumor; TMA, tissue microarray; IOD, integrated optical density; LC3B,
microtubule-associated proteins 1A/1B light chain 3B; sequestosome-1, SQSTM1
or p62; PI3K, phosphoinositide 3-kinase; mTOR, mammalian target of rapamycin;
IHC, immunohistochemistry; TCGA, The Cancer Genome Atlas; SM, seminoma;
NSM, non-seminoma; FPKM, fragments per kilobase million.
RESULTS
Reduced Expression of ATGs in TGCT
TGCT are derived from primordial germ cells/gonocytes that
failed to differentiate into spermatogonia. They are classified
as seminomas or non-seminomas and display a wide range of
histological subtypes. Seminomas possess pluripotent potential,
but are more indolent, whereas non-seminomas are often
differentiated and more aggressive (11–13). mRNA expression
data for the ATGs in TGCT was extracted from the TCGA
consortium data base (https://cancergenome.nih.gov/) and is
presented in Figure 1A (n = 157). The individual ATGs show
a differential expression in these cancer tissues (Figure 1A).
However, whether any ATGmRNA level differed between cancer
and normal tissues could not be concluded owing to a lack of
normal testis tissue samples.
With TMAs containing punches of 10 non-neoplastic
testicular tissues retrieved from contralateral testicular biopsies
of patients with TGCT and punches from 191 TGCT tumor
patients, we employed immunohistochemical methods to stain
for key autophagy regulators, ATG1, ATG5, and ATG16L1.
Tumors were classified according to the 2016WHO classification
(11). Homogenous and intense staining of these proteins was
observed in the parenchyma of normal testis tissues. However,
the staining intensities were consistently and strongly reduced
in TGCT cells (Figure 1B). Quantification of the IODs of these
proteins showed a significant reduction in the expression of
ATG1, ATG5, and ATG16L1 (Figure 1C). ATG1 and ATG16L1
are even further reduced in seminoma (SM) compared to non-
seminoma (NSM) (Figure 1C). In contrast, the expression of
ATG5 did not differ significantly between the two subtypes
(Figure 1C). Taken together, the reduced expression of ATGs in
TGCT strongly suggest a possible decrease in autophagy, which
might promote survival of gonocytes (14).
Reduced Level of Autophagy in TGCT
To prove our hypothesis that autophagy is reduced in TGCT,
we stained the TMAs with an antibody against LC3B, a
protein which is required for formation of the characteristic
organelles called autophagosomes, in which engulfed cellular
contents are degraded (3). Homogenous and strong staining
in the parenchyma was observed in normal testicular tissues
in contrast to tumor tissues that showed instead a rather
weak staining of LC3B (Figure 2A). Quantification of IODs of
LC3B demonstrated a significant reduction of LC3B expression
in TGCT compared to normal tissues (Figure 2A). Since
autophagy is a dynamic process and increased amounts of
autophagosomes or upregulation of LC3B could also be the
consequence of inhibited autophagosome degradation (3), we
investigated the levels of p62, which is normally degraded
via autophagy (3). Interestingly, consistently weak staining of
p62 was observed in normal parenchyma of the testicular
tissue, whereas it is strongly stained in the tumor tissue
(Figure 2B). Quantification of IOD of p62 demonstrated a
significant increase in p62 in tumor compared with normal
tissues (Figure 2B). Moreover, based on a previous publication
(15), we specifically analyzed the expression of 28 ATGs in 27
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FIGURE 1 | ATG1, ATG5, and ATG16L1 are downregulated in TGCT. (A) The mRNA expression of ATGs in TGCT. mRNA expression data of ATGs in TGCT (n = 157)
were extracted from the TCGA consortium data base and are presented as a heat map as well as bar diagrams. (B) Representative images of IHC of ATG1, ATG5,
and ATG16L1. Scale bars: 50 µm. (C) Quantification of the IODs of these proteins using Image Pro Plus software. ANOVA followed by the Bonferroni test was
performed with data shown on the right panel.
different normal tissues. These data showed that the 28 ATG
genes are highly expressed (high FPKM values) in normal testis
tissue, suggesting that the testis exhibits a high level of autophagy
(Figure 2C). Taken together, these data indicate a reduced
autophagic activity in TGCT probably owing to downregulation
of the ATGs.
The Expression of ATG Proteins Correlates
With Markers of Autophagic Activity
To test our hypothesis that the reduced level of autophagy in
TGCT possibly resulted from downregulation of key ATGs, we
performed a correlation analysis between the expression levels of
ATGs to those of LC3B and p62. As shown in (Figure 2D), the
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FIGURE 2 | Basal level of autophagy is reduced in TGCT. (A) Representative images of IHC staining of LC3B and its quantification. Scale bars: 50µm. (B)
Representative images of IHC staining of p62 and its quantification. Scale bars: 50µm. (C) Log2 FPKM of the gene expression data of 28 ATGs in 27 normal tissues
based on findings in a previous publication (15). (D) The IODs of these proteins were applied to Prism software for correlation analysis between ATGs and LC3B or
p62. The Pearson r values and p-values obtained from the software are presented. (E) Correlation between p62 and LC3B was analyzed and presented like described
in (D).
expression of the three investigated ATGs correlated significantly
with LC3B expression, especially ATG5 (Figure 2D). However,
only ATG1, but not ATG5 or ATG16L1 negatively correlated with
p62 (Figure 2D). Additionally, p62 levels correlated negatively
with those of LC3B (Figure 2E). Although not causal, this
correlation analysis does give a strong hint that the reduced
basal level of autophagy in TGCT is at least partially owing to
a reduction in the expression of the investigated ATGs.
DISCUSSION
Analyzing autophagy in tissues remains difficult. Due to the
dynamic features of autophagy it is important to consider levels
of both LC3B and p62 as well as other ATGs in order to obtain a
general picture of the autophagic network. The analysis of large
cohorts of patients clearly helps to obtain conclusive data. It must
be noted that the expression levels of LC3B and/or p62 do not
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necessarily reflects the level of autophagy (16). For an adequate
interpretation of the level of autophagy, autophagy inducers,
and/or inhibitors must be applied to monitor autophagic flux.
For a retrospective study of autophagy, differences in patients’
cohorts and experimental procedures, especially the source of the
antibodies, may also lead to different conclusions. For example,
in another study, no significant difference in autophagy was
found between non-neoplastic and TGCT patients using a p62
antibody different from ours (17). Nevertheless, our evaluation
of the expression of ATGs as well as LC3B and p62 strongly
suggests a reduction in autophagy in TGCT and points to a
possible inhibitory function of the autophagic pathway in the
tumorigenesis of TGCT.
CONCLUSION
We have observed reduced expression of ATG1, ATG5, and
ATG16L1 as well as decreased LC3B and elevated p62 levels,
suggesting a diminished basal autophagy in TGCT and a likely
tumor-suppressive function of autophagy in the tumorigenesis of
TGCT.
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